Processa Pharmaceuticals, Inc. (PCSA)
1.78
-0.03
(-1.66%)
USD |
NASDAQ |
Oct 26, 16:00
1.78
0.00 (0.00%)
After-Hours: 16:52
Processa Pharmaceuticals Market Cap : 4.972M for Oct. 26, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.056M |
| October 22, 2026 | 5.196M |
| October 21, 2026 | 4.916M |
| October 20, 2026 | 5.000M |
| October 19, 2026 | 4.833M |
| October 16, 2026 | 4.721M |
| October 15, 2026 | 4.693M |
| October 14, 2026 | 4.511M |
| October 13, 2026 | 4.944M |
| October 12, 2026 | 5.308M |
| October 09, 2026 | 4.246M |
| October 08, 2026 | 3.771M |
| October 07, 2026 | 3.967M |
| October 06, 2026 | 4.246M |
| October 05, 2026 | 4.162M |
| October 02, 2026 | 4.497M |
| October 01, 2026 | 4.525M |
| September 30, 2026 | 4.581M |
| September 29, 2026 | 4.916M |
| September 28, 2026 | 5.140M |
| September 25, 2026 | 5.140M |
| September 24, 2026 | 5.168M |
| September 23, 2026 | 5.280M |
| September 22, 2026 | 5.252M |
| September 21, 2026 | 5.140M |
| Date | Value |
|---|---|
| September 18, 2026 | 5.475M |
| September 17, 2026 | 5.308M |
| September 16, 2026 | 5.168M |
| September 15, 2026 | 5.466M |
| September 14, 2026 | 5.252M |
| September 11, 2026 | 5.810M |
| September 10, 2026 | 5.168M |
| September 09, 2026 | 5.559M |
| September 08, 2026 | 6.034M |
| September 04, 2026 | 5.754M |
| September 03, 2026 | 5.726M |
| September 02, 2026 | 5.866M |
| September 01, 2026 | 5.726M |
| August 31, 2026 | 5.726M |
| August 28, 2026 | 5.754M |
| August 27, 2026 | 5.894M |
| August 26, 2026 | 5.950M |
| August 25, 2026 | 6.090M |
| August 24, 2026 | 6.062M |
| August 21, 2026 | 5.810M |
| August 20, 2026 | 5.992M |
| August 19, 2026 | 6.006M |
| August 18, 2026 | 5.866M |
| August 17, 2026 | 5.950M |
| August 14, 2026 | 6.788M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.652B |
| Corcept Therapeutics, Inc. | 9.414B |
| Veru, Inc. | 37.85M |
| Johnson & Johnson | 641.50B |
| Eli Lilly & Co. | 1.205T |
Market Cap Related Metrics
| Price | 1.78 |
| Earnings Yield | -314.0% |